当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 现金流量表

博瑞医药

(688166)

  

流通市值:217.05亿  总市值:217.05亿
流通股本:4.23亿   总股本:4.23亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金520,621,567.05275,672,789.11,010,560,886.9813,792,937.47
  收到的税费返还30,178,607.0326,337,116.3956,504,504.1648,813,455.71
  收到其他与经营活动有关的现金11,591,785.5215,897,264.3550,805,215.9641,416,883.97
  经营活动现金流入小计562,391,959.6317,907,169.841,117,870,607.02904,023,277.15
  购买商品、接受劳务支付的现金115,408,176.1258,550,490.52204,463,410.07286,207,185.98
  支付给职工以及为职工支付的现金153,579,704.2165,357,589.92265,530,091.9204,656,001.24
  支付的各项税费34,678,294.5823,387,168.2881,969,233.4667,140,777.52
  支付其他与经营活动有关的现金145,113,003.6863,618,928.61320,348,554.49226,429,610.38
  经营活动现金流出小计448,779,178.59210,914,177.33872,311,289.92784,433,575.12
  经营活动产生的现金流量净额113,612,781.01106,992,992.51245,559,317.1119,589,702.03
二、投资活动产生的现金流量:
  收回投资收到的现金46,705,100-110,170,515.3461,749,840.21
  取得投资收益收到的现金--1,579,324.8733,041.28
  处置固定资产、无形资产和其他长期资产收回的现金净额17,664.426,160303,641.610
  收到的其他与投资活动有关的现金--43,788,077.636,498,977.6
  投资活动现金流入小计46,722,764.426,160155,841,559.4298,281,859.09
  购建固定资产、无形资产和其他长期资产支付的现金327,294,945.44221,710,325.76257,199,197.47251,051,326.55
  投资支付的现金106,730,462.885,593,449.23338,783,886.09272,103,670.16
  支付其他与投资活动有关的现金---0
  投资活动现金流出小计434,025,408.32227,303,774.99595,983,083.56523,154,996.71
  投资活动产生的现金流量净额-387,302,643.9-227,297,614.99-440,141,524.14-424,873,137.62
三、筹资活动产生的现金流量:
  吸收投资收到的现金181,800,000181,800,000103,000,0000
  其中:子公司吸收少数股东投资收到的现金181,800,000181,800,000103,000,0000
  取得借款收到的现金496,899,300316,351,900802,077,074.15595,962,819.75
  收到其他与筹资活动有关的现金70,000,00020,000,00021,000,000-
  筹资活动现金流入小计748,699,300518,151,900926,077,074.15595,962,819.75
  偿还债务支付的现金409,263,943.65319,943,643.65786,710,467.93627,876,477.53
  分配股利、利润或偿付利息支付的现金80,139,714.6120,113,633.68135,734,274.41118,858,800.88
  支付其他与筹资活动有关的现金15,184,5028,703,637.2228,107,235.6722,994,592.31
  筹资活动现金流出小计504,588,160.26348,760,914.55950,551,978.01769,729,870.72
  筹资活动产生的现金流量净额244,111,139.74169,390,985.45-24,474,903.86-173,767,050.97
四、汇率变动对现金及现金等价物的影响6,309,982.473,123,026.272,118,247.621,333,672.34
五、现金及现金等价物净增加额-23,268,740.6852,209,389.24-216,938,863.28-477,716,814.22
  加:期初现金及现金等价物余额754,101,930.95754,101,930.95971,040,794.23971,040,794.23
  期末现金及现金等价物余额730,833,190.27806,311,320.19754,101,930.95493,323,980.01
补充资料:
  净利润1,657,076.47-141,263,284.54-
  资产减值准备2,766,161.91-19,942,512.38-
  固定资产和投资性房地产折旧68,653,413.53-91,406,078.94-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧68,653,413.53-91,406,078.94-
  无形资产摊销2,991,127.05-5,877,357.74-
  长期待摊费用摊销6,014,313.45-9,187,226.6-
  处置固定资产、无形资产和其他长期资产的损失--0-
  固定资产报废损失208,240.64-148,435.21-
  公允价值变动损失-1,585,851.81-5,699,782.83-
  财务费用22,569,997.3-50,515,554.66-
  投资损失5,427,848.31-11,633,803.45-
  递延所得税-8,009,207.93--31,266,124.51-
  其中:递延所得税资产减少-8,009,207.93--31,266,124.51-
    递延所得税负债增加--0-
  存货的减少-10,571,118.75--35,549,548.22-
  经营性应收项目的减少61,037,558.21--149,927,051.69-
  经营性应付项目的增加-46,429,041.47-84,399,593.34-
  其他--0-
  债务转为资本--0-
  一年内到期的可转换公司债券--0-
  融资租入固定资产--0-
  现金的期末余额730,833,190.27-754,101,930.95-
  减:现金的期初余额754,101,930.95-971,040,794.23-
  加:现金等价物的期末余额--0-
  减:现金等价物的期初余额--0-
  现金及现金等价物的净增加额-23,268,740.68--216,938,863.28-
公告日期2025-08-292025-04-182025-04-032024-10-30
审计意见(境内)标准无保留意见
TOP↑